Concentrations of Methotrexate Elimination after High Dose Infusion and Its Influencing Factors

HUA Ying,ZHAO Wei-hong,LU Xin-tian

2010-01-01

Abstract:Objective To analyze the concentrations of methotrexate(MTX) elimination after high dose infusion and to explore the influencing factors.Methods Thirty-three children with acute lymphoblastic leukemia(ALL) and 230 courses of high-dose MTX 3 g·m-2 24-hour infusions were included in the study.MTX concentrations at 1 h,6 h,23 h(concentration in steady state) and 48 h(C48) after infusion were measured.If C48>0.40 μmol·L-1,MTX concentration at 72 h(C72) after infusion was measured.Sampling was continued every 24 hours until MTX concentration<0.25 μmol·L-1.Results There was a wide inter-course variability in MTX concentrations at each sampling time during elimination after high dose infusion.MTX was excreted quickly in most infusions;and there were 201(87%) infusions which C72 were<0.25 μmol·L-1.MTX was excreted slowly in a few infusions;and there were 14(6%) infusions which C96>0.25 μmol·L-1.There was a wide inter-course variability in C48;the range was 0.02-8.86 μmol·L-1;and the median was 0.20 μmol·L-1.There were 24(10%) infusions which C48>1 μmol·L-1,and it was defined as "delayed" MTX elimination.Intra-patient variability in C48 was significant(P=0.000).Risk factors that correlated with increased C48 of MTX were boys,abnormal urine routine tests within 1 week before infusions,concurrent infections within 2 weeks before infusions,and co-administration of ceftriaxone(P<0.05).Risk factors that correlated with delayed MTX elimination were high MTX concentration in steady state,low MTX total clearance,high plasma glutarmyl transferase(P<0.05).Binary logistic regression analysis showed that the main risk factors of delayed MTX elimination were high MTX concentration in steady state,abnormal urine routine tests within 1 week before infusions,and concurrent infections within 2 weeks before infusions.Conclusions There is a wide inter-course variability in MTX concentrations at each sampling time during elimination after high-dose MTX 3 g·m-2 24-hour infusions.Many risk factors may delay MTX elimination.